Investing.com -- Morgan Stanley upgraded Logitech (NASDAQ:LOGI) International to "Equal-weight" from "Underweight" citing consensus long-term growth expectations and improved valuation. Shares of the computer keyboard and mouse maker Logitech were up more than 2% in premarket trading.
Brokerage said consensus expectations now forecasting a 4% compound annual growth rate through 2027, a 100bps above Morgan Stanley’s expectations
The brokerage lifted its price target for the computer peripherals maker to $92 from $73, reflecting an 18x target price-to-earnings multiple for fiscal 2027 EPS of $5.10.
Morgan Stanley (NYSE:MS) highlighted improved PC and peripherals data, less discounting in the December quarter, and disciplined operating expenses as factors driving its fiscal 2025 EPS forecast 3% above the Street's expectations. It also sees a potential near-term catalyst if Logitech raises fiscal 2025 operating income guidance during its earnings report next Tuesday.
Expects Logitech to post a modestly stronger FY25 outlook than anticipated, forecasting a revenue of $4.43 billion, operating income of $757 million and an EPS of $4.71
Brokerage pointed to balanced risks and rewards, with a bull case valuation of $122 and a bear case of $64. Downside risks include weaker consumer demand and import tariffs from China, while upside drivers could include stronger cycles, cost controls, or M&A.
Related Articles
Morgan Stanley raises rating, price target on Logitech, shares up
Volkswagen to make added investments in US, CFO says in Davos
Netflix musical 'Emilia Perez' leads Oscar nominations
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.